May 23, 2024
The PSMID acknowledges the recent uptick in COVID-19 cases in Metro Manila, most of whom are mild. Although a few patients with moderate to severe COVID-19 cases have been hospitalized, the numbers are currently well within the capacity of the healthcare system to manage. PSMID members are cooperating with national and local health authorities in monitoring and reporting cases of COVID-19 and other severe acute respiratory illnesses.
We urge everyone, especially the elderly and immunocompromised patients, to remain vigilant. We can effectively prevent the spread of COVID-19 and other respiratory illnesses by the following measures:
Let’s stay safe! Let’s keep our community healthy.
PSMID National Board and Council of Advisers
Standing Committee for Health Emergency On Calamities, Outbreaks, Disasters, and
Emerging (CODE) Infections 2024
Dr. Jemelyn Garcia, FPCP, FPSMID
Dr. Maria Sonia Salamat, FPCP, FPSMID
Dr. Marja B. Buensalido, FPCP, FPSMID
Dr. Emmerson Gale Vista, FPDS
Dr. Clarisse Garcia-Mendoza, FPDS
Dr. Kingbherly L. Li, FPCP, FPSMID
Dr. Yvette Silubrico, FPCP, FPSMID
Dr. Chatie Olasiman, FPCP, FPSMID
Dr. Ma. Charmian Hufano, FPCP, FPSMID
Dr. Mitzie Lou Osabel, FPCP, FPSMID
Dr. Janice C. Caoili, FPCP, FPSMID
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.